Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,447 | 34 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $340.38 | 10 | $0 (2023) |
| ABBVIE INC. | $295.67 | 6 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $193.69 | 3 | $0 (2024) |
| Novo Nordisk Inc | $189.24 | 6 | $0 (2024) |
| Gilead Sciences, Inc. | $124.54 | 1 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $108.38 | 2 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $96.42 | 1 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $28.38 | 1 | $0 (2022) |
| Daiichi Sankyo Inc. | $26.28 | 1 | $0 (2024) |
| Amgen Inc. | $18.27 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $737.20 | 10 | Bayer Healthcare Pharmaceuticals Inc. ($193.69) |
| 2023 | $285.22 | 11 | Lilly USA, LLC ($162.84) |
| 2022 | $424.50 | 13 | Lilly USA, LLC ($177.54) |
All Payment Transactions
34 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/21/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $59.70 | General |
| Category: Cardio-renal | ||||||
| 10/16/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $93.76 | General |
| Category: Respiratory | ||||||
| 08/30/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $121.82 | General |
| Category: Cardio-renal | ||||||
| 05/30/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $124.54 | General |
| 05/15/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $18.27 | General |
| Category: Inflammation | ||||||
| 05/01/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $80.51 | General |
| Category: NEUROSCIENCE | ||||||
| 04/10/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $12.17 | General |
| Category: Cardio-renal | ||||||
| 03/28/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $103.73 | General |
| Category: Obesity | ||||||
| 02/29/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $96.42 | General |
| Category: Neuroscience | ||||||
| 01/10/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $26.28 | General |
| Category: Iron Deficiency Anemia | ||||||
| 10/26/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $22.87 | General |
| Category: NEUROSCIENCE | ||||||
| 10/11/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $10.29 | General |
| Category: Diabetes | ||||||
| 09/25/2023 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $12.97 | General |
| Category: Endocrinology | ||||||
| 09/12/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | Cash or cash equivalent | $112.45 | General |
| Category: Diabetes | ||||||
| 08/30/2023 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $34.93 | General |
| Category: NEUROSCIENCE | ||||||
| 08/02/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.70 | General |
| Category: Diabetes | ||||||
| 07/12/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $13.47 | General |
| Category: Diabetes | ||||||
| 05/01/2023 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.80 | General |
| Category: Diabetes | ||||||
| 02/09/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $17.48 | General |
| Category: Diabetes | ||||||
| 02/01/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $10.83 | General |
| Category: Diabetes | ||||||
| 01/04/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $15.43 | General |
| Category: Diabetes | ||||||
| 12/14/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $12.20 | General |
| Category: NEUROSCIENCE | ||||||
| 10/12/2022 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $14.62 | General |
| Category: Respiratory | ||||||
| 10/03/2022 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.67 | General |
| Category: Diabetes | ||||||
| 09/14/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $27.05 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 381 | 562 | $64,606 | $31,728 |
| 2022 | 9 | 360 | 472 | $59,577 | $27,480 |
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 178 | 342 | $51,250 | $25,215 | 49.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 29 | 29 | $5,046 | $3,075 | 60.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 23 | 23 | $4,370 | $1,117 | 25.6% |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | Office | 2023 | 35 | 47 | $1,692 | $987.47 | 58.4% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 35 | 35 | $665.00 | $528.85 | 79.5% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 32 | 32 | $608.00 | $483.52 | 79.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 13 | 14 | $350.00 | $129.50 | 37.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 17 | 17 | $510.00 | $113.28 | 22.2% |
| 81002 | Urinalysis, manual test | Office | 2023 | 19 | 23 | $115.00 | $78.43 | 68.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 220 | 323 | $48,450 | $22,226 | 45.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 38 | 38 | $7,220 | $3,064 | 42.4% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2022 | 14 | 14 | $980.00 | $712.16 | 72.7% |
| G0506 | Comprehensive assessment of and care planning for patients requiring chronic care management services (list separately in addition to primary monthly care management service) | Office | 2022 | 14 | 16 | $1,280 | $648.48 | 50.7% |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | Office | 2022 | 13 | 14 | $504.00 | $303.26 | 60.2% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 12 | 12 | $228.00 | $180.24 | 79.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 13 | 17 | $425.00 | $151.63 | 35.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 12 | 12 | $360.00 | $103.33 | 28.7% |
| 81002 | Urinalysis, manual test | Office | 2022 | 24 | 26 | $130.00 | $89.82 | 69.1% |
About Jayna Raub
Jayna Raub is a General Practice healthcare provider based in Apache Junction, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/28/2021. The National Provider Identifier (NPI) number assigned to this provider is 1962173096.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Jayna Raub has received a total of $1,447 in payments from pharmaceutical and medical device companies, with $737.20 received in 2024. These payments were reported across 34 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($1,447).
As a Medicare-enrolled provider, Raub has provided services to 741 Medicare beneficiaries, totaling 1,034 services with total Medicare billing of $59,208. Data is available for 2 years (2022–2023), covering 18 distinct procedure/service records.
Practice Information
- Specialty General Practice
- Location Apache Junction, AZ
- Active Since 09/28/2021
- Last Updated 09/28/2021
- Taxonomy Code 208D00000X
- Entity Type Individual
- NPI Number 1962173096
Products in Payments
- MOUNJARO (Drug) $290.52
- Kerendia (Drug) $193.69
- QULIPTA (Drug) $154.69
- CREON (Drug) $118.11
- Wegovy (Drug) $103.73
- SPRAVATO (Drug) $96.42
- AIRSUPRA (Drug) $93.76
- Rybelsus (Drug) $46.64
- Ozempic (Drug) $38.87
- JARDIANCE (Drug) $29.47
- INJECTAFER (Drug) $26.28
- UBRELVY (Drug) $22.87
- Otezla (Drug) $18.27
- BREZTRI (Drug) $14.62
- Dexcom G6 Transmitter (Medical Supply) $12.97
- ONPATTRO (Drug) $12.70
- TRULICITY (Drug) $12.55
- EMGALITY (Drug) $7.84
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
General Practice Doctors in Apache Junction
Dr. Taylor Kim, Dds, DDS
General Practice — Payments: $389,189
Dr. John Bigler, D.d.s, D.D.S
General Practice — Payments: $5,163
Dr. Reza Abedi, Dds, DDS
General Practice — Payments: $4,968
Dr. Michael Winkelman, Dmd, DMD
General Practice — Payments: $2,028
Lowell Arbuckle
General Practice — Payments: $46.99
Dr. Udechukwu Iheduru, Dmd, DMD
General Practice — Payments: $29.33